Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation

Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation

Abstract Background The severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is extremely variable, ranging from asymptomatic patients to those who develop severe acute respiratory distress syndrome (ARDS). As for now, there are still no really effective therapies for c...

Full description

Bibliographic Details
Main Authors: Francesco Menzella, Matteo Fontana, Carlo Salvarani, Marco Massari, Patrizia Ruggiero, Chiara Scelfo, Chiara Barbieri, Claudia Castagnetti, Chiara Catellani, Giorgia Gibellini, Francesco Falco, Giulia Ghidoni, Francesco Livrieri, Gloria Montanari, Eleonora Casalini, Roberto Piro, Pamela Mancuso, Luca Ghidorsi, Nicola Facciolongo
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Critical Care
Subjects:
SARS-CoV-2
COVID-19
Acute respiratory distress syndrome
Tocilizumab
Noninvasive ventilation
Online Access:http://link.springer.com/article/10.1186/s13054-020-03306-6

Internet

http://link.springer.com/article/10.1186/s13054-020-03306-6

Similar Items